Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers

por Brenner, B, Siris, N, Rakowsky, E, Fenig, E, Sulkes, A, Lurie, H
Publicado 2002

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines

por Uziel, O, Fenig, E, Nordenberg, J, Beery, E, Reshef, H, Sandbank, J, Birenbaum, M, Bakhanashvili, M, Yerushalmi, R, Luria, D, Lahav, M
Publicado 2005